iBio
IBIO
#9403
Rank
โ‚น7.47 B
Marketcap
โ‚น216.26
Share price
-2.86%
Change (1 day)
-27.35%
Change (1 year)

EPS for iBio (IBIO)

EPS in 2025 (TTM): -โ‚น131.39

According to iBio's latest financial reports the company's current EPS (TTM) is -โ‚น139.93. an increase over its 2024 EPS that were of -โ‚น590.62.

EPS history for iBio from 2007 to 2025

Annual EPS

Year EPS Change
2025-โ‚น159.01-73.08%
2024-โ‚น590.62-93.88%
2023-โ‚น9,649-8.14%
2022-โ‚น10,50492.67%
2021-โ‚น5,452-80.33%
2020-โ‚น27,714-35.11%
2019-โ‚น42,707-38.96%
2018-โ‚น69,966-6.1%
2017-โ‚น74,50936.67%
2016-โ‚น54,51933.33%
2015-โ‚น40,88950%
2014-โ‚น27,259-53.85%
2013-โ‚น59,062-7.14%
2012-โ‚น63,605-64.1%
2011-โ‚น1,77,18777.27%
2010-โ‚น99,951144.44%
2009-โ‚น40,88912.93%
2008-โ‚น36,20812.2%
2007-โ‚น32,271

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น1,012-823.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Genocea Biosciences
GNCA
-โ‚น47.25-66.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-โ‚น724.19 417.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น128.12-191.56%๐Ÿ‡บ๐Ÿ‡ธ USA